Related Experiment Video
Updated: May 10, 2026

Rapid and Specific Detection of Acinetobacter baumannii Infections Using a Recombinase Polymerase Amplification/Cas12a-based System
Published on: April 25, 2025
Nosocomial infection by sequence type 357 multidrug-resistant Acinetobacter baumannii isolates in a neonatal
Ji Youn Sung1, Sun Hoe Koo, Hye Hyun Cho
1Department of Biomedical Laboratory Science, Far East University, Eumseong, Korea.
Abstract:
Acinetobacter baumannii is an important microorganism responsible for a number of nosocomial outbreaks, in particular, in intensive care units (ICUs). We investigated a nosocomial infection caused by multidrug-resistant (MDR) A. baumannii in a neonatal intensive care unit (NICU) in Korea. A. baumannii isolates were characterized using Etest (AB Biodisk, Sweden), two multiplex PCR assays, and multilocus sequence typing (MLST) scheme. PCR and PCR mapping experiments were performed for detecting and characterizing the determinants of antimicrobial resistance. Eight strains isolated from an NICU belonged to European (EU) clone II and revealed only one sequence type (ST), namely, ST357. All the isolates were susceptible to imipenem but were resistant to amikacin, gentamicin, ceftazidime, cefepime, and ciprofloxacin. To the best of our knowledge, this is the first report of a nosocomial infection in an NICU in Korea caused by ST357 MDR/carbapenem-susceptible A. baumannii strains. This result demonstrates that nosocomial outbreaks of MDR/carbapenem-susceptible strains as well as MDR/carbapenem-resistant isolates may occur in NICUs.
Insights
Multidrug-resistant Acinetobacter baumannii caused a nosocomial outbreak in a Korean neonatal intensive care unit. The study identified European clone II, ST357, susceptible to imipenem but resistant to other antibiotics.
Area of Science:
- Microbiology
- Infectious Diseases
- Public Health
Background:
- Acinetobacter baumannii is a significant cause of hospital-acquired infections, particularly in intensive care units.
- Neonatal intensive care units (NICUs) are vulnerable to outbreaks of multidrug-resistant (MDR) pathogens.
- Understanding the specific strains and resistance patterns of MDR A. baumannii is crucial for infection control.
Purpose of the Study:
- To investigate a nosocomial outbreak caused by multidrug-resistant Acinetobacter baumannii in a Korean NICU.
- To characterize the genetic profile and antimicrobial resistance patterns of the isolated A. baumannii strains.
- To report the first occurrence of ST357 MDR/carbapenem-susceptible A. baumannii in a Korean NICU.
Main Methods:
- Isolates were identified and characterized using Etest for antimicrobial susceptibility.
- Multiplex PCR assays and multilocus sequence typing (MLST) were employed for genetic analysis.
- PCR and PCR mapping were used to identify antimicrobial resistance determinants.
Main Results:
- Eight A. baumannii strains isolated from the NICU belonged to the European (EU) clone II, specifically sequence type (ST) 357.
- All isolates were susceptible to imipenem.
- Isolates exhibited resistance to amikacin, gentamicin, ceftazidime, cefepime, and ciprofloxacin.
Conclusions:
- This is the first report of a nosocomial infection in a Korean NICU caused by ST357 MDR/carbapenem-susceptible A. baumannii.
- The findings highlight the potential for nosocomial outbreaks involving MDR/carbapenem-susceptible strains in NICUs.
- Effective infection control strategies are essential to manage MDR A. baumannii in vulnerable neonatal populations.
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Clinical Significance of Antibiotic Resistance
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
Atypical Pneumonia
Acute Pyelonephritis I: Introduction
